| Open | 0 |
| LTP | 0 |
| Previous Close | 0 |
| Day High | 0 |
| Day Low | 0 |
| Volume | 0 |
| Code : | ABMINTLTD |
| Name : | ABM International Limited |
| Country : | India |
| Sector : | |
| Industry: | Specialty Chemicals |
| Market CAP : | 122 Cr |
| Stock P/E: | 12.72 |
| ROCE: | 56.87% |
| Book Value: | 24.07 |
| Dividend Yield : | 0.04% |
| Most Recent Quarter : | 2021-06-30 |
| Revenue/Sales TTM : | 154 Cr |
| Operating Margin TTM : | 0.0673% |
| Return On Equity TTM : | 0.57% |
| Profit Margin : | 0.06% |
| Market Capitalization : | 122 Cr |
| EBITDA : | 10 Cr |
| Book Value : | 24.07 |
| PERatio : | 12.72 |
| Dividend Share : | 0.042 |
| Earnings Share : | 10.16 |
| Gross Profit TTM : | 12 Cr |
| Quarterly Earnings Growth YOY : | 0% |
| Dividend Yield : | 0.0004% |
| Quarterly Revenue GrowthYOY : | 1.29 |
| Diluted Eps TTM : | 10.16 |
| Trailing PE : | 12.72 |
| Price Sales TTM : | 1.27 |
| Enter Prise Value : | 106 Cr |
| Enter Prise Value Ebidta : | 0 |
| Forward PE : | 0 |
| Price Book MRQ : | 9.03 |
| Enter Prise Value Revenue : | 1.18 |
| Forward Annual Dividend Rate : | 0 |
| Payout Ratio : | 0 |
| Ex Dividend Date : | 2016-09-15 |
| Last Split Date : | 2021-07-27 |
| Forward Annual Dividend Yield : | 0 |
| Dividend Date : | |
| Last Split Factor : | 4:5 |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fibonacci | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Camarilla | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Classic | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days 50 Day MA |
125.39 |
| Days 200 Day MA |
92.27 |
| Days 52 Week High |
0 |
| Days 52 Week Low |
0 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Jun 2021 | 46 Cr | 0 | -1 Cr | 25 Lac | 0 | 0 | -1 Cr | 0 | 0 |
| Mar 2021 | 30 Cr | 0 | 1 Cr | 2 Cr | 0 | 20 Lac | 1 Cr | 0 | 20 Lac |
| Dec 2020 | 60 Cr | 0 | 8 Cr | 2 Cr | 0 | 2 Cr | 9 Cr | 0 | 2 Cr |
| Sep 2020 | 18 Cr | 17 Cr | 1 Cr | 12 Lac | 8 k | 0 | 1 Cr | -8 k | 0 |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Mar 2021 | 129 Cr | 0 | 10 Cr | 49 Lac | 0 | 2 Cr | 8 Lac | 0 | 2 Cr |
| Mar 2020 | 98 Cr | 0 | -5 Cr | 45 Lac | 0 | 2 Cr | 8 Lac | 0 | 2 Cr |
| Mar 2019 | 77 Cr | 80 Cr | -2 Cr | 50 Lac | 0 | -1 Cr | 8 Lac | 0 Cr | -1 Cr |
| Mar 2018 | 89 Cr | 88 Cr | 0 Cr | 62 Lac | 0 | 45 Lac | 13 Lac | 7 Lac | 45 Lac |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Jun 2021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mar 2021 | 31 Cr | 25 Cr | 5 Cr | 8 Cr | 29 Lac | 8 Cr | 23 Cr |
| Dec 2020 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sep 2020 | 18 Cr | 13 Cr | 74 Lac | 5 Cr | 25 Lac | 5 Cr | 13 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2021 | 31 Cr | 25 Cr | 5 Cr | 8 Cr | 29 Lac | 8 Cr | 23 Cr |
| Mar 2020 | 29 Cr | 23 Cr | 11 Cr | 16 Cr | 26 Lac | 15 Cr | 13 Cr |
| Mar 2019 | 26 Cr | 17 Cr | 7 Cr | 8 Cr | 15 Lac | 8 Cr | 18 Cr |
| Mar 2018 | 32 Cr | 24 Cr | 0 | 13 Cr | 13 Lac | 13 Cr | 20 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Jun 2021 | 0 | 0 | 0 | 0 | -1 Cr | 0 | 0 |
| Mar 2021 | 0 | 0 | 0 | 0 | 1 Cr | 7 Lac | 67 k |
| Dec 2020 | 0 | 0 | 0 | 0 | 8 Cr | 0 | 0 |
| Sep 2020 | 0 | 0 | 0 | 0 | 1 Cr | 8 Lac | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Mar 2021 | 23 Lac | 0 | 6 Cr | 0 | 10 Cr | 7 Lac | 67 k |
| Mar 2020 | 36 Lac | 0 | -3 Cr | 0 | -5 Cr | 79 Lac | 10 Lac |
| Mar 2019 | -1 Cr | 0 | -7 Cr | 29 Lac | -2 Cr | 19 Lac | 10 Lac |
| Mar 2018 | 29 Lac | 0 | 3 Cr | 13 Lac | 0 Cr | 23 Lac | 49 k |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 0.00 | 0.00 | 0.00 | 0.00 |
0.00 |
0.00 | 0.00 | 0.00 |
ABM International Limited trades in plastic raw materials worldwide. It sells PVC resins, finished leather products, DOP, urea, etc. The company was founded in 1983 and is based in New Delhi, India.
| Open | 0 |
| LTP | 0 |
| Previous Close | 0 |
| Day High | 0 |
| Day Low | 0 |
| Volume | 0 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Lloyds Steels Industries Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GMR Infrastructure Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3i Infotech Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company WIPRO |
LTP 309.9 |
Change 11.55 |
Gain 3.87 % |
|
Company TCS |
LTP 4152 |
Change 116.15 |
Gain 2.88 % |
|
Company HDFCBANK |
LTP 1671.9 |
Change 29.5 |
Gain 1.8 % |
|
Company BAJAJFINSV |
LTP 1742.55 |
Change 25.55 |
Gain 1.49 % |
|
Company BAJFINANCE |
LTP 7394.95 |
Change 103.3 |
Gain 1.42 % |
|
Company TATAMOTORS |
LTP 744.35 |
Change -16.4 |
Loss -16.4 % |
|
Company AXISBANK |
LTP 959.6 |
Change -10.6 |
Loss -10.6 % |
|
Company ONGC |
LTP 263.69 |
Change -2.11 |
Loss -2.11 % |
|
Company SBIN |
LTP 753.45 |
Change -5.6 |
Loss -5.6 % |
|
Company BPCL |
LTP 278.3 |
Change -1.9 |
Loss -1.9 % |
Motilal Oswal's research report on Dixon TechnologiesDixon Technologies (Dixon) reported better-than-expected revenue and EBITDA, driven by strong performance of the mobile and EMS segment, while PAT stood lower than our estimates on higher depreciation, interest, and minority interest. The company’s revenue/EBITDA jumped 117%/112% YoY for 3QFY25. The mobile and EMS segment continues to benefit ...
Shares of Multi Commodity Exchange of India (MCX) crashed 10 percent on January 21. This comes after brokerage Morgan Stanley issued an 'underweight' call for the stock, stating that the firm's Q3 net profit has fallen below its estimate.At 11:20 am on January 21, MCX shares were trading nearly 11% lower at Rs 5,388 apiece.MCX had released its quarterly results for October-December in the post-mar...
Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target price of Rs 2,150, reflecting a 7 percent downside from the previous close.The international brokerage said that the domestic formulations business remains weak, driven by slower growth in acute therapies,...
The Q3 earnings season kicked off right in the middle of market chaos—caught between pre-budget buzz, US policy jitters, India’s faltering growth, and sky-high valuations. January, already cursed with weak seasonality, has been a rollercoaster of volatility, leaving investors in a pool of caution.One standout trend this season? Investors are getting seriously choosy. This marks a stark differe...
Sellwin Traders, which reported a 90 percent jump in income for the December quarter, on Sunday said it has signed a pact with UAE-based Secorbit FZCO for developing a blockchain-based tokenization platform for equities, bonds, and real-world assets for USD 3 million (around Rs 26 crore).The platform will be developed for Secorbit to “enable the tokenization of equities, bonds, and real-world as...
